Home / Japan / PRISM BioLab Co.,LTD
PRISM BioLab Co.,LTD
Short position disclosed on September 16, 2026.
0.51% of the capital sold short
1 disclosing fund
14 disclosures on record
Evolution of the disclosed total
0%0.5%1%1.5%2%
Aug 13Aug 22Aug 31Sep 9Sep 18
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Nomura International plc | 0.51% | new | September 16, 2026 |
Get the moves on PRISM BioLab Co.,LTD by mail.
No account: one address, one link to confirm, one link to stop in every message.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| September 16, 2026 | Nomura International plc | 0.51% | still open |
| September 9, 2026 | モルガン・スタンレーmufg証券株式会社 | 0.49% | |
| September 8, 2026 | Nomura International plc | 0.68% | |
| September 3, 2026 | Nomura International plc | 0.78% | |
| September 2, 2026 | Nomura International plc | 0.80% | |
| September 1, 2026 | モルガン・スタンレーmufg証券株式会社 | 0.59% | |
| August 27, 2026 | Nomura International plc | 0.77% | |
| August 27, 2026 | モルガン・スタンレーmufg証券株式会社 | 0.68% | |
| August 24, 2026 | Nomura International plc | 0.88% | |
| August 21, 2026 | Nomura International plc | 0.91% | |
| August 21, 2026 | モルガン・スタンレーmufg証券株式会社 | 0.79% | |
| August 20, 2026 | Nomura International plc | 0.88% | |
| August 10, 2026 | Nomura International plc | 0.90% | |
| August 4, 2026 | モルガン・スタンレーmufg証券株式会社 | 0.89% |
Download 14 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in Japan
- ReYuu Japan Inc. 12.36% of the capital sold short
- Towa Corporation 10.49% of the capital sold short
- TESS Holdings Co.,Ltd. 6.97% of the capital sold short
- Unitika LTD. 6.96% of the capital sold short
- Jibannet Holdings Co.,Ltd. 6.90% of the capital sold short
- Nomura Micro Science Co.,Ltd. 6.52% of the capital sold short
- Toyo Engineering Corporation 6.29% of the capital sold short
- JSH Co.,Ltd. 5.97% of the capital sold short
- Datasection Inc. 5.83% of the capital sold short
- Def consulting,inc. 5.76% of the capital sold short
- Tri Chemical Laboratories Inc. 5.71% of the capital sold short
- Toho Zinc Co.,Ltd. 5.27% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, PRISM BioLab Co.,LTD, source JPX, data as at September 16, 2026, https://www.quivad.com/action/prism-biolab-co-ltd